The physiological disposition of 2(2,6-dichloroanilino)-2-imidazoline (St-155).
D000814:Aniline Compounds / Q000652:urine; D000818:Animals; D000959:Antihypertensive Agents / Q000378:metabolism*; D001798:Blood Proteins / Q000378:metabolism; D001921:Brain / Q000378:metabolism; D002247:Carbon Isotopes; D002415:Cats; D002849:Chromatography, Gas; D004058:Diffusion; D005753:Gastric Mucosa / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D007093:Imidazoles / Q000097:blood / Q000378:metabolism*; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D008297:Male; D009132:Muscles / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D011485:Protein Binding; D051381:Rats; D012463:Saliva / Q000378:metabolism; D013363:Submandibular Gland / Q000378:metabolism; D013997:Time Factors
D000814:Aniline Compounds; D000959:Antihypertensive Agents; D001798:Blood Proteins; D002247:Carbon Isotopes; D007093:Imidazoles